MedTrace Logo

Utilization of HIV Drug Resistance Testing in Treatment Experienced Patients (UTILIZE Study)

NCT00615563 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 246

Last updated 2013-11-21

No results posted yet for this study

Summary

The primary objective of this trial was to assess the presence of susceptibility to tipranavir and other ARVs of the HIV-1 isolates in treatment experienced patients. The secondary objective was to examine clinicians' use of HIV drug resistance testing in treatment experienced patients currently failing a PI based HAART regimen.

Conditions

  • HIV Infections

Interventions

BEHAVIORAL

NO BI Drug administered

Sponsors & Collaborators

Principal Investigators

  • Boehringer Ingelheim Study Coordinator · B.I. Pharmaceuticals,Inc./Ridgefield

Eligibility

Min Age
18 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-03-31
Primary Completion
2008-01-31
Completion
2008-01-31

Countries

  • United States
  • Puerto Rico

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00615563 on ClinicalTrials.gov